196 related articles for article (PubMed ID: 29770564)
1. Physiological and oncogenic roles of the PRL phosphatases.
Hardy S; Kostantin E; Hatzihristidis T; Zolotarov Y; Uetani N; Tremblay ML
FEBS J; 2018 Nov; 285(21):3886-3908. PubMed ID: 29770564
[TBL] [Abstract][Full Text] [Related]
2. Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism.
Hardy S; Kostantin E; Wang SJ; Hristova T; Galicia-Vázquez G; Baranov PV; Pelletier J; Tremblay ML
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2925-2934. PubMed ID: 30718434
[TBL] [Abstract][Full Text] [Related]
3. Phosphocysteine in the PRL-CNNM pathway mediates magnesium homeostasis.
Gulerez I; Funato Y; Wu H; Yang M; Kozlov G; Miki H; Gehring K
EMBO Rep; 2016 Dec; 17(12):1890-1900. PubMed ID: 27856537
[TBL] [Abstract][Full Text] [Related]
4. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
5. Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.
Rubio T; Köhn M
Biochem Soc Trans; 2016 Oct; 44(5):1305-1312. PubMed ID: 27911713
[TBL] [Abstract][Full Text] [Related]
6. Targeting PRL phosphatases in hematological malignancies.
Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of the PRL phosphatases.
Rios P; Li X; Köhn M
FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.
Giménez-Mascarell P; Oyenarte I; Hardy S; Breiderhoff T; Stuiver M; Kostantin E; Diercks T; Pey AL; Ereño-Orbea J; Martínez-Chantar ML; Khalaf-Nazzal R; Claverie-Martin F; Müller D; Tremblay ML; Martínez-Cruz LA
J Biol Chem; 2017 Jan; 292(3):786-801. PubMed ID: 27899452
[TBL] [Abstract][Full Text] [Related]
9. The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities.
Gehring K; Kozlov G; Yang M; Fakih R
J Biol Chem; 2022 Jan; 298(1):101471. PubMed ID: 34890645
[TBL] [Abstract][Full Text] [Related]
10. Targeting phosphatases of regenerating liver (PRLs) in cancer.
Wei M; Korotkov KV; Blackburn JS
Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
[TBL] [Abstract][Full Text] [Related]
11. Localizing PRL-2 expression and determining the effects of dietary Mg(2+) on expression levels.
Gungabeesoon J; Tremblay ML; Uetani N
Histochem Cell Biol; 2016 Jul; 146(1):99-111. PubMed ID: 27015884
[TBL] [Abstract][Full Text] [Related]
12. Burst kinetics and CNNM binding are evolutionarily conserved properties of phosphatases of regenerating liver.
Fakih R; Goldstein RH; Kozlov G; Gehring K
J Biol Chem; 2023 Apr; 299(4):103055. PubMed ID: 36822330
[TBL] [Abstract][Full Text] [Related]
13. PRL-3 phosphatase and cancer metastasis.
Al-Aidaroos AQ; Zeng Q
J Cell Biochem; 2010 Dec; 111(5):1087-98. PubMed ID: 21053359
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase of regenerating liver maintains cellular magnesium homeostasis.
Yoshida A; Funato Y; Miki H
Biochem J; 2018 Mar; 475(6):1129-1139. PubMed ID: 29487165
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma.
Reich R; Hadar S; Davidson B
Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048
[TBL] [Abstract][Full Text] [Related]
16. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.
Wang Y; Li ZF; He J; Li YL; Zhu GB; Zhang LH; Li YL
Int J Colorectal Dis; 2007 Oct; 22(10):1179-84. PubMed ID: 17440740
[TBL] [Abstract][Full Text] [Related]
17. PRL-1/2 phosphatases control TRPM7 magnesium-dependent function to regulate cellular bioenergetics.
Hardy S; Zolotarov Y; Coleman J; Roitman S; Khursheed H; Aubry I; Uetani N; Tremblay ML
Proc Natl Acad Sci U S A; 2023 Apr; 120(14):e2221083120. PubMed ID: 36972446
[TBL] [Abstract][Full Text] [Related]
18. Phosphatase of regenerating liver: a novel target for cancer therapy.
Campbell AM; Zhang ZY
Expert Opin Ther Targets; 2014 May; 18(5):555-69. PubMed ID: 24579927
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.
Vandsemb EN; Bertilsson H; Abdollahi P; Størkersen Ø; Våtsveen TK; Rye MB; Rø TB; Børset M; Slørdahl TS
J Transl Med; 2016 Mar; 14():71. PubMed ID: 26975394
[TBL] [Abstract][Full Text] [Related]
20. Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine.
Diamond RH; Peters C; Jung SP; Greenbaum LE; Haber BA; Silberg DG; Traber PG; Taub R
Am J Physiol; 1996 Jul; 271(1 Pt 1):G121-9. PubMed ID: 8760115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
